CBMT-03. A NOVEL METABOLIC PET TRACER STRATEGY TO DETERMINE EARLY EFFECTS OF TUMOR TREATING FIELDS (TTFIELDS)

Pyruvate kinase M2 (PKM2) is a key marker of cancer metabolic reprogramming since it catalyzes the final step in glycolysis. [18F]DASA-23 is a novel radiotracer that measures aberrantly-expressed PKM2 in glioblastoma (GBM). Tumor treating fields (TTFields), the application of alternating electric fi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Patel, Chirag, Beinat, Corinne, Xie, Yuanyang, Haywood, Tom, Murty, Surya, Chang, Edwin, Gambhir, Sanjiv
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216937/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.122
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky